STAAR Surgical 미래 성장

Future 기준 확인 4/6

STAAR Surgical (는) 각각 연간 33.7% 및 13.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 31% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 7.7% 로 예상됩니다.

주요 정보

33.7%

수익 성장률

31.0%

EPS 성장률

Medical Equipment 수익 성장	17.0%
매출 성장률	13.5%
향후 자기자본 수익률	7.7%
애널리스트 커버리지	Good
마지막 업데이트	17 Dec 2024

최근 미래 성장 업데이트

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 10

Recent updates

STAAR Surgical Company's (NASDAQ:STAA) Earnings Haven't Escaped The Attention Of Investors

Nov 29

Return Trends At STAAR Surgical (NASDAQ:STAA) Aren't Appealing

Oct 24

STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize

Sep 05

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 10

Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

Apr 26

STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge

Apr 05

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

Mar 25

STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

Mar 13

STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Mar 07

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Jan 31

With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Jan 05

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Nov 30

Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Nov 12

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Oct 25

Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Aug 24

Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Jul 02

Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Jun 17

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

May 13

A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Mar 26

STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Mar 12

Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Feb 13

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Jan 28

Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Dec 15

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

Dec 01

What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Oct 26

Keep Adding To STAAR Surgical Longs, Buy Thesis Remains

Sep 20

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

Sep 05

STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

Aug 21

수익 및 매출 성장 예측

NasdaqGM:STAA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	445	38	31	55	12
12/31/2025	386	18	19	39	14
12/31/2024	343	6	7	31	14
9/27/2024	341	22	26	47	N/A
6/28/2024	333	17	14	37	N/A
3/29/2024	326	15	21	41	N/A
12/29/2023	322	21	-4	15	N/A
9/29/2023	310	20	-34	-14	N/A
6/30/2023	306	26	-1	16	N/A
3/31/2023	295	33	17	35	N/A
12/30/2022	284	40	18	36	N/A
9/30/2022	279	38	22	41	N/A
7/1/2022	262	34	24	39	N/A
4/1/2022	243	29	19	33	N/A
12/31/2021	230	28	30	44	N/A
10/1/2021	217	23	44	55	N/A
7/2/2021	206	21	32	42	N/A
4/2/2021	179	11	28	36	N/A
1/1/2021	163	6	13	21	N/A
10/2/2020	156	9	2	11	N/A
7/3/2020	148	7	4	13	N/A
4/3/2020	153	13	7	17	N/A
1/3/2020	150	14	16	26	N/A
9/27/2019	142	9	11	18	N/A
6/28/2019	135	8	9	15	N/A
3/29/2019	129	6	7	11	N/A
12/28/2018	124	5	11	13	N/A
9/28/2018	118	4	10	12	N/A
6/29/2018	109	3	N/A	7	N/A
3/30/2018	97	1	N/A	6	N/A
12/29/2017	91	-2	N/A	3	N/A
9/29/2017	88	-2	N/A	2	N/A
6/30/2017	84	-5	N/A	0	N/A
3/31/2017	84	-6	N/A	3	N/A
12/30/2016	82	-12	N/A	1	N/A
9/30/2016	81	-13	N/A	-1	N/A
7/1/2016	80	-13	N/A	-1	N/A
4/1/2016	78	-12	N/A	-3	N/A
1/1/2016	77	-7	N/A	-2	N/A
10/2/2015	73	-8	N/A	-4	N/A
7/3/2015	72	-9	N/A	-5	N/A
4/3/2015	74	-9	N/A	-8	N/A
1/2/2015	75	-8	N/A	-8	N/A
10/3/2014	77	-7	N/A	-5	N/A
7/4/2014	76	-3	N/A	-1	N/A
4/4/2014	74	-1	N/A	1	N/A
1/3/2014	72	0	N/A	3	N/A

애널리스트 미래 성장 예측

수입 대 저축률: STAA 의 연간 예상 수익 증가율( 33.7% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: STAA 의 연간 수익( 33.7% ) US 시장( 15.2% 보다 빠르게 성장할 것으로 예상됩니다. 15.2% 연간).

고성장 수익: STAA 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: STAA 의 수익(연간 13.5% ) US 시장( 9.1% 보다 빠르게 성장할 것으로 예상됩니다. 9.1% 연간).

고성장 수익: STAA 의 수익(연간 13.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: STAA 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 7.7 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/23 11:08
장 마감 주가	2024/12/20 00:00
수익	2024/09/27
연간 수익	2023/12/29

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

STAAR Surgical Company 24 애널리스트 중 14 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Joanne Wuensch	BMO Capital Markets U.S. (Historical)
Michael Gorman	BTIG
John Young	Canaccord Genuity

STAAR Surgical 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

STAAR Surgical Company Maintains Earnings Guidance for the Year 2024

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

STAAR Surgical Company Revises Earnings Guidance for the Fiscal Year 2024

Consensus EPS estimates fall from profit to US$0.008 loss

STAAR Surgical Company Reiterates Earnings Guidance for the Fiscal Year 2024

Price target increased by 7.1% to US$46.81

Recent updates

STAAR Surgical Company's (NASDAQ:STAA) Earnings Haven't Escaped The Attention Of Investors

STAAR Surgical Company Maintains Earnings Guidance for the Year 2024

Return Trends At STAAR Surgical (NASDAQ:STAA) Aren't Appealing

STAAR Surgical Company to Report Q3, 2024 Results on Oct 30, 2024

STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

STAAR Surgical Company Revises Earnings Guidance for the Fiscal Year 2024

STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear

STAAR Surgical Company to Report Q2, 2024 Results on Aug 07, 2024

The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Consensus EPS estimates fall from profit to US$0.008 loss

STAAR Surgical Company Reiterates Earnings Guidance for the Fiscal Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

STAAR Surgical Company, Annual General Meeting, Jun 20, 2024

Price target increased by 7.1% to US$46.81

Price target increased by 7.2% to US$43.81

Consensus EPS estimates increase by 153%

STAAR Surgical Company to Report Q1, 2024 Results on May 08, 2024

STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge

STAAR Surgical Company Provides Sales Guidance for the First Quarter Ended March 29, 2024

STAAR Surgical Unveils New EVO ICL Data and Latest Innovation for 2024

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

Now 20% overvalued after recent price rise

STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

STAAR Surgical Company Announces Board Changes

STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Consensus EPS estimates fall by 97%

STAAR Surgical Company Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS exceeds analyst expectations

STAAR Surgical Company to Report Q4, 2023 Results on Feb 26, 2024

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Broadwood Partners Engages in Discussions with STAAR Surgical

Staar Surgical Company Provides Sales Guidance for the Fiscal 2024

With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Now 22% undervalued after recent price drop

STAAR Surgical Company Announces Board Changes

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Now 24% undervalued after recent price drop

Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Now 21% undervalued after recent price drop

New major risk - Earnings quality

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

STAAR Surgical Company to Report Q3, 2023 Results on Nov 01, 2023

Price target decreased by 7.4% to US$52.38

Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Consensus EPS estimates fall by 51%

New minor risk - Profit margin trend

Second quarter 2023 earnings: EPS misses analyst expectations

Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Staar Surgical Company Announces Sales Guidance for 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Chief Technology Officer recently sold US$51k worth of stock

Chief Financial Officer exercised options to buy US$106k worth of stock.

STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Full year 2022 earnings released: EPS: US$0.81 (vs US$0.52 in FY 2021)

Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

STAAR Surgical Company to Report Q4, 2022 Results on Feb 22, 2023

Investor sentiment improved over the past week

STAAR Surgical Company Provides Sales Guidance for the Fourth Quarter of 2022

Now 26% undervalued after recent price drop

Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising